A more critical role of genetics is linked to cholangiocarcinoma progression: NKG2D gene polymorphisms detected in patients with PSC were associated with a higher risk of cholangiocarcinoma and could identify patients at risk (110). Here, KLRK1 is linked to cholangiocarcinoma.